Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

240 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A phase II study of high-dose epirubicin (EPI) plus cyclophosphamide (CPA) with G-CSF for breast cancer patients with visceral metastases or hormone-independent tumors: a trial of the Japan Clinical Oncology Group.
Takashima S, Saeki T, Adachi I, Watanabe T, Sasaki Y, Murai H, Tabei T, Ogita M, Sano M, Kanda K, Shimoyama M. Takashima S, et al. Among authors: ogita m. Jpn J Clin Oncol. 1997 Oct;27(5):325-30. doi: 10.1093/jjco/27.5.325. Jpn J Clin Oncol. 1997. PMID: 9390210 Clinical Trial.
Long-term results of breast-conserving treatment for early-stage breast cancer in Japanese women from multicenter investigation.
Ohsumi S, Sakamoto G, Takashima S, Koyama H, Shin E, Suemasu K, Nishi T, Nakamura S, Iino Y, Iwase T, Ikeda T, Teramoto S, Fukutomi T, Komaki K, Sano M, Sugiyama K, Miyoshi K, Kamio T, Ogita M. Ohsumi S, et al. Among authors: ogita m. Jpn J Clin Oncol. 2003 Feb;33(2):61-7. doi: 10.1093/jjco/hyg014. Jpn J Clin Oncol. 2003. PMID: 12629055
A phase I/II study of continuous intra-arterial chemotherapy using an implantable reservoir for the treatment of liver metastases from breast cancer: a Japan Clinical Oncology Group (JCOG) study 9113. JCOG Breast Cancer Study Group.
Ikeda T, Adachi I, Takashima S, Ogita M, Aoyama H, Sano M, Ando J, Tabei T, Tominaga T, Enomoto K, Kanda K, Fukutomi T, Shimoyama M. Ikeda T, et al. Among authors: ogita m. Jpn J Clin Oncol. 1999 Jan;29(1):23-7. doi: 10.1093/jjco/29.1.23. Jpn J Clin Oncol. 1999. PMID: 10073147 Clinical Trial.
[Early phase II dose-finding study of exemestane in postmenopausal patients with advanced/recurrent breast cancer].
Tabei T, Ogita M, Hirata K, Satomi S, Kimura M, Abe R, Morishita Y, Kimura M, Andou J, Higashi Y, Yoshino K, Tominaga K, Kajiwara T, Kitajima M, Koyanagi Y, Watanabe T, Yamaguchi S, Watanabe M, Toyama K, Kanda K, Kashiki Y, Miura S, Kobayashi Z, Aoyama H, Miyazaki I, Oka T, Koyama H, Kinoshita H, Monden M, Takai S, Yayoi E, Kobayashi T, Takatsuka Y, Kajiwara T, Sonoo H, Toge T, Takashima S, Nomura Y, Nagao K, Fujita Y. Tabei T, et al. Among authors: ogita m. Gan To Kagaku Ryoho. 2002 Jul;29(7):1199-209. Gan To Kagaku Ryoho. 2002. PMID: 12146001 Clinical Trial. Japanese.
Phase III study to evaluate the use of high-dose chemotherapy as consolidation of treatment for high-risk postoperative breast cancer: Japan Clinical Oncology Group study, JCOG 9208.
Tokuda Y, Tajima T, Narabayashi M, Takeyama K, Watanabe T, Fukutomi T, Chou T, Sano M, Igarashi T, Sasaki Y, Ogura M, Miura S, Okamoto S, Ogita M, Kasai M, Kobayashi T, Fukuda H, Takashima S, Tobinai K; Autologous Bone Marrow Transplantation Study Group; Breast Cancer Study Group of the Japan Clinical Oncology Group (JCOG). Tokuda Y, et al. Among authors: ogita m. Cancer Sci. 2008 Jan;99(1):145-51. doi: 10.1111/j.1349-7006.2007.00639.x. Epub 2007 Oct 25. Cancer Sci. 2008. PMID: 17970786 Free article. Clinical Trial.
1-hexylcarbamoyl-5-fluorouracil + cyclophosphamide + tamoxifen versus CMF + tamoxifen in women with lymph node-positive breast cancer after primary surgery: a randomized controlled trial.
Tominaga T, Kimura M, Asaga T, Yoshida M, Awane H, Koyama H, Takatsuka Y, Mitsuyama S, Ikeda T, Ogita M, Aoyama H, Sano M, Abe R, Nishi T, Wada T, Danno M, Toi M, Takashima S. Tominaga T, et al. Among authors: ogita m. Oncol Rep. 2004 Oct;12(4):797-803. Oncol Rep. 2004. PMID: 15375502 Clinical Trial.
240 results